Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2015 1
2016 1
2017 1
2019 1
2020 1
2021 1
2022 4
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Risk factors for disease severity and increased medical resource utilization in respiratory syncytial virus (+) hospitalized children: A descriptive study conducted in four Belgian hospitals.
Proesmans M, Rector A, Keyaerts E, Vandendijck Y, Vermeulen F, Sauer K, Reynders M, Verschelde A, Laffut W, Garmyn K, Fleischhackl R, Bollekens J, Ispas G. Proesmans M, et al. Among authors: vandendijck y. PLoS One. 2022 Jun 6;17(6):e0268532. doi: 10.1371/journal.pone.0268532. eCollection 2022. PLoS One. 2022. PMID: 35666728 Free PMC article.
Risk factors and medical resource utilization in US adults hospitalized with influenza or respiratory syncytial virus in the Hospitalized Acute Respiratory Tract Infection study.
Hartnett J, Donga P, Ispas G, Vandendijck Y, Anderson D, House S, Suner S. Hartnett J, et al. Among authors: vandendijck y. Influenza Other Respir Viruses. 2022 Sep;16(5):906-915. doi: 10.1111/irv.12994. Epub 2022 Apr 26. Influenza Other Respir Viruses. 2022. PMID: 35474419 Free PMC article.
Measuring respiratory syncytial virus infection severity in hospitalized children using the Pediatric Respiratory Syncytial Virus Electronic Severity and Outcome Rating System (PRESORS).
Vandendijck Y, Scott J, Heerwegh D, Van Der Elst W, Witek J, Sinha R, Fennema H. Vandendijck Y, et al. Influenza Other Respir Viruses. 2022 Nov;16(6):1091-1100. doi: 10.1111/irv.13028. Epub 2022 Aug 14. Influenza Other Respir Viruses. 2022. PMID: 35965419 Free PMC article.
Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire.
Falsey AR, Walsh EE, Osborne RH, Vandendijck Y, Ren X, Witek J, Kang D, Chan E, Scott J, Ispas G. Falsey AR, et al. Among authors: vandendijck y. Influenza Other Respir Viruses. 2022 Jan;16(1):79-89. doi: 10.1111/irv.12903. Epub 2021 Sep 2. Influenza Other Respir Viruses. 2022. PMID: 34472708 Free PMC article.
Evaluation of symptoms in respiratory syncytial virus infection in adults: psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire™ symptom scores.
Osborne RH, Nelson LM, Fehnel S, Williams N, Bender RH, Ziemiecki R, Gymnopoulou E, De Paepe E, Vandendijck Y, Norcross L, Heijnen E, Ispas G, Comeaux C, Callendret B, Chan EKH, Scott JA. Osborne RH, et al. Among authors: vandendijck y. J Patient Rep Outcomes. 2023 Jun 1;7(1):51. doi: 10.1186/s41687-023-00593-9. J Patient Rep Outcomes. 2023. PMID: 37261682 Free PMC article.
13 results